🇺🇸 FDA
Pipeline program

Medium-dosage COVID-19 Vaccine,Inactivated

PRO-nCOV-3003

Phase 3 mab terminated

Quick answer

Medium-dosage COVID-19 Vaccine,Inactivated for COVID-19 is a Phase 3 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
COVID-19
Phase
Phase 3
Modality
mab
Status
terminated

Clinical trials